{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T01:47:57Z","timestamp":1773798477959,"version":"3.50.1"},"reference-count":22,"publisher":"Oxford University Press (OUP)","issue":"11","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2017,11,1]]},"DOI":"10.1093\/ndt\/gfw460","type":"journal-article","created":{"date-parts":[[2016,12,24]],"date-time":"2016-12-24T07:56:19Z","timestamp":1482566179000},"page":"1918-1926","source":"Crossref","is-referenced-by-count":24,"title":["One-year efficacy and safety of the iron-based phosphate binder sucroferric oxyhydroxide in patients on peritoneal dialysis"],"prefix":"10.1093","volume":"32","author":[{"given":"J\u00fcrgen","family":"Floege","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adrian C","family":"Covic","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Markus","family":"Ketteler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Johannes","family":"Mann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anjay","family":"Rastogi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bruce","family":"Spinowitz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Viatcheslav","family":"Rakov","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laura J","family":"Lisk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stuart M","family":"Sprague","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2017,2,23]]},"reference":[{"key":"key\n\t\t\t\t20171102070519_gfw460-B1","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1681\/ASN.2008060609","article-title":"Phosphorus binders and survival on hemodialysis","volume":"20","year":"2009","journal-title":"J Am Soc Nephrol"},{"key":"key\n\t\t\t\t20171102070519_gfw460-B2","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1053\/j.ackd.2010.12.003","article-title":"Phosphate and cardiovascular disease","volume":"18","year":"2011","journal-title":"Adv Chronic Kidney Dis"},{"key":"key\n\t\t\t\t20171102070519_gfw460-B3","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1097\/00041552-200111000-00003","article-title":"Control of serum phosphorus: implications for coronary artery calcification and calcific uremic arteriolopathy (calciphylaxis)","volume":"10","year":"2001","journal-title":"Curr Opin Nephrol Hypertens"},{"key":"key\n\t\t\t\t20171102070519_gfw460-B4","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1038\/ki.2008.130","article-title":"Hyperphosphatemia of chronic kidney disease","volume":"74","year":"2008","journal-title":"Kidney Int"},{"key":"key\n\t\t\t\t20171102070519_gfw460-B5","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1038\/ki.2009.60","article-title":"Oral phosphate binders","volume":"75","year":"2009","journal-title":"Kidney Int"},{"key":"key\n\t\t\t\t20171102070519_gfw460-B6","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.1056\/NEJMra0912522","article-title":"Oral phosphate binders in patients with kidney failure","volume":"362","year":"2010","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t20171102070519_gfw460-B7","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1038\/nrneph.2011.112","article-title":"Pharmacology, efficacy and safety of oral phosphate binders","volume":"7","year":"2011","journal-title":"Nat Rev Nephrol"},{"key":"key\n\t\t\t\t20171102070519_gfw460-B8","doi-asserted-by":"crossref","first-page":"697","DOI":"10.2215\/CJN.00560206","article-title":"The case against calcium-based phosphate binders","volume":"1","year":"2006","journal-title":"Clin J Am Soc Nephrol"},{"key":"key\n\t\t\t\t20171102070519_gfw460-B9","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1093\/ndt\/gfh125","article-title":"Determinants of progressive vascular calcification in haemodialysis patients","volume":"19","year":"2004","journal-title":"Nephrol Dial Transplant"},{"key":"key\n\t\t\t\t20171102070519_gfw460-B10","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/2191-1991-1-1","article-title":"Considerations about the effectiveness and cost effectiveness of therapies in the treatment of hyperphosphataemia","volume":"1","year":"2011","journal-title":"Health Econ Rev"},{"key":"key\n\t\t\t\t20171102070519_gfw460-B11","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.2215\/CJN.00290109","article-title":"Pill burden, adherence, hyperphosphatemia, and quality of life in maintenance dialysis patients","volume":"4","year":"2009","journal-title":"Clin J Am Soc Nephrol"},{"key":"key\n\t\t\t\t20171102070519_gfw460-B12","first-page":"19","article-title":"Examining patient perceptions of phosphate binders","volume":"12","year":"2007","journal-title":"Br J Ren Med"},{"key":"key\n\t\t\t\t20171102070519_gfw460-B13","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1681\/ASN.2011060607","article-title":"Global trends in rates of peritoneal dialysis","volume":"23","year":"2012","journal-title":"J Am Soc Nephrol"},{"key":"key\n\t\t\t\t20171102070519_gfw460-B14","doi-asserted-by":"crossref","first-page":"251","DOI":"10.5414\/CN108119","article-title":"The iron-based phosphate binder PA21 has potent phosphate binding capacity and minimal iron release across a physiological pH range in vitro","volume":"81","year":"2014","journal-title":"Clin Nephrol"},{"key":"key\n\t\t\t\t20171102070519_gfw460-B15","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1038\/ki.2014.58","article-title":"A phase III study of the efficacy and safety of a novel iron-based phosphate binder in dialysis patients","volume":"86","year":"2014","journal-title":"Kidney Int"},{"key":"key\n\t\t\t\t20171102070519_gfw460-B16","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1093\/ndt\/gfv006","article-title":"Long-term effects of iron-based phosphate binder, sucroferric oxyhydroxide, in dialysis patients","volume":"30","year":"2015","journal-title":"Nephrol Dial Transplant"},{"key":"key\n\t\t\t\t20171102070519_gfw460-B17","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1053\/j.ajkd.2006.11.027","article-title":"Impact of the Kidney Disease Outcomes Quality Initiative (KDOQI) clinical practice guidelines for bone metabolism and disease in a large dialysis network","volume":"49","year":"2007","journal-title":"Am J Kidney Dis"},{"key":"key\n\t\t\t\t20171102070519_gfw460-B18","first-page":"525","article-title":"Challenge of phosphorus control in hemodialysis patients: a problem of adherence?","volume":"23","year":"2010","journal-title":"J Nephrol"},{"key":"key\n\t\t\t\t20171102070519_gfw460-B19","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1093\/ndt\/gfq602","article-title":"Improving CKD-MBD management in haemodialysis patients: barrier analysis for implementing better practice","volume":"26","year":"2011","journal-title":"Nephrol Dial Transplant"},{"key":"key\n\t\t\t\t20171102070519_gfw460-B20","first-page":"1363","article-title":"Iron-related parameters in dialysis patients treated with sucroferric oxyhydroxide","volume":"32","year":"2017","journal-title":"Nephrol Dial Transplant"},{"key":"key\n\t\t\t\t20171102070519_gfw460-B21","first-page":"953","article-title":"Preclinical pharmacokinetics, pharmacodynamics and safety of sucroferric oxyhydroxide","volume":"15","year":"2014","journal-title":"Curr Drug Metab"},{"key":"key\n\t\t\t\t20171102070519_gfw460-B22","doi-asserted-by":"crossref","first-page":"4","DOI":"10.5414\/CNP74004","article-title":"PA21: a novel phosphate binder for the treatment of hyperphosphatemia in chronic kidney disease","volume":"74","year":"2010","journal-title":"Clin Nephrol"}],"container-title":["Nephrology Dialysis Transplantation"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/ndt\/article-pdf\/32\/11\/1918\/21509695\/gfw460.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,12,1]],"date-time":"2017-12-01T13:50:26Z","timestamp":1512136226000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ndt\/article-lookup\/doi\/10.1093\/ndt\/gfw460"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,2,23]]},"references-count":22,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2017,2,23]]},"published-print":{"date-parts":[[2017,11,1]]}},"URL":"https:\/\/doi.org\/10.1093\/ndt\/gfw460","relation":{},"ISSN":["0931-0509","1460-2385"],"issn-type":[{"value":"0931-0509","type":"print"},{"value":"1460-2385","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2017,11]]},"published":{"date-parts":[[2017,2,23]]}}}